Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma
Clinical trial NCT05004064 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05004064
- Sponsor
- University College, London
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-30
- Primary completion
- 2026-06-08
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.